Evidence map›Paper›PMID 41271645›Full record

ArticleBlood cancer journal2025

Outcomes of CAR T-Cell therapy in relapsed/refractory multiple myeloma by race: a multicenter real-world study.

Manisha Bhutani, Alma Habib, Andrew Vegel, Ami Ndiaye, Emily Struble, Hira Shaikh, Darryl Chang, Christopher Strouse, Kimberly M Green, Kevin Graf and 8 more

Abstract readLetter
In one paragraph

Article in Blood cancer journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. T-Cell Engagers TargetingInternational journal of molecular sciences · 2026
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Manisha BhutaniDivision of Hematology, Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA. manisha.bhutani@advocatehealth.org.ORCID http://orcid.org/0000-0002-9019-7438
Alma HabibDivision of Hematology, The Ohio State University, Columbus, OH, USA.
Andrew VegelDivision of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Ami NdiayeDivision of Hematology, Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA.
Emily StrubleDivision of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Hira ShaikhDivision of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Darryl ChangDivision of Hematology, Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA.
Christopher StrouseDivision of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Kimberly M GreenDivision of Hematology-Oncology, Medical University of South Carolina, Charleston, SC, USA.
Kevin GrafDivision of Hematology-Oncology, Medical University of South Carolina, Charleston, SC, USA.
Muhammad Umair MushtaqDivision of Hematologic Malignancies & Cellular Therapeutics, The University of Kansas Cancer Center, Kansas City, KS, USA.
Zahra MahmoudjafariDivision of Hematologic Malignancies & Cellular Therapeutics, The University of Kansas Cancer Center, Kansas City, KS, USA.ORCID http://orcid.org/0000-0002-3168-2521
Joseph P McGuirkDivision of Hematologic Malignancies & Cellular Therapeutics, The University of Kansas Cancer Center, Kansas City, KS, USA.ORCID http://orcid.org/0000-0002-0539-4796
Peter VoorheesDivision of Hematology, Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA.ORCID http://orcid.org/0000-0003-1661-718X
Abdullah Mohammad KhanDivision of Hematology, The Ohio State University, Columbus, OH, USA.ORCID http://orcid.org/0000-0003-2166-2583
Al-Ola AbdallahDivision of Hematologic Malignancies & Cellular Therapeutics, The University of Kansas Cancer Center, Kansas City, KS, USA.
Nausheen AhmedDivision of Hematologic Malignancies & Cellular Therapeutics, The University of Kansas Cancer Center, Kansas City, KS, USA.ORCID http://orcid.org/0000-0003-4336-4982
Shebli AtrashDivision of Hematology, Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA.ORCID http://orcid.org/0000-0003-4547-7534

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41271645
PMCPMC12638965

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.